Clinical Trial Update: Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding safety study of BIIB014 in early-stage Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIIB014

Snippet

Sponsor: Biogen | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED